Literature DB >> 14991321

Effect of keratinocyte growth factor and activin on cell growth in the human prostatic cancer cell line LNCaP.

Bernhard Planz1, Horia Oltean, Thomas Deix, Sandra D Kirley, Qi Fa Wang, W S McDougal, Michael Marberger.   

Abstract

Keratinocyte growth factor (KGF) has paracrine properties in the human prostate which stimulate epithelial cell growth. Activins have profound effects on cell growth and function in the human prostate, and are expressed in LNCaP, DU 145 and PC3 cells. LNCaP cells were characterized by immuncytochemistry, an immunoassay and polymerase chain reaction. A 3[H]thymidine assay was used with 0.01-10 nM dihydrotestosterone, 10 micro M flutamide, 1-100 ng/ml KGF and 3 nM activin. LNCaP cells expressed Ki67, PSA, cytokeratins (8, 18, 19, 14, 15) androgenreceptor but no KGF protein. LNCaP cells showed telomerase activity. Furthermore, ARmRNA (365 bp), but no KGF or KGFRmRNA were expressed. KGF ELISA detected no intracellular or secreted KGF. DHT (1, 10 and 100 nM) and KGF (10 and 100 ng/ml) significantly stimulated LNCaP cell proliferation. However, flutamide and 3 nM activin A significantly decreased cell proliferation in the presence and absence of KGF. The results of our experiments support the hypothesis that cell growth and proliferative characteristics of LNCaP cells are modulated by KGF and activin A.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991321     DOI: 10.1007/s00345-003-0391-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  20 in total

1.  Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.

Authors:  M F Lin; M S Lee; R Garcia-Arenas; F F Lin
Journal:  Cell Biol Int       Date:  2000       Impact factor: 3.612

Review 2.  Follistatin and activin: a potential intrinsic regulatory system within diverse tissues.

Authors:  L V DePaolo; T A Bicsak; G F Erickson; S Shimasaki; N Ling
Journal:  Proc Soc Exp Biol Med       Date:  1991-10

3.  Identification of an activin-follistatin growth modulatory system in the human prostate: secretion and biological activity in primary cultures of prostatic epithelial cells.

Authors:  Q Wang; S Tabatabaei; B Planz; C W Lin; P M Sluss
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

4.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

5.  Keratinocyte growth factor expression in hormone insensitive prostate cancer.

Authors:  H Y Leung; P Mehta; L B Gray; A T Collins; C N Robson; D E Neal
Journal:  Oncogene       Date:  1997-08-28       Impact factor: 9.867

6.  "Decoy" of androgen-responsive element induces apoptosis in LNCaP cells.

Authors:  K Kuratsukuri; K Sugimura; K Harimoto; H Kawashima; T Kishimoto
Journal:  Prostate       Date:  1999-10-01       Impact factor: 4.104

7.  Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate.

Authors:  M Ittman; A Mansukhani
Journal:  J Urol       Date:  1997-01       Impact factor: 7.450

Review 8.  Activation of the androgen receptor by polypeptide growth factors and cellular regulators.

Authors:  Z Culig; A Hobisch; M V Cronauer; A Hittmair; C Radmayr; G Bartsch; H Klocker
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter.

Authors:  C Fasciana; A C van der Made; P W Faber; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1996-03-27       Impact factor: 3.575

View more
  1 in total

Review 1.  Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.

Authors:  Kenichiro Ishii; Sanai Takahashi; Yoshiki Sugimura; Masatoshi Watanabe
Journal:  J Clin Med       Date:  2018-04-02       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.